Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

LeonaBio (LONA) Shares Issued (2020 - 2023)

LeonaBio (LONA) reported Shares Issued of $99000.0 for Q1 2023, down 52.86% year-over-year from $210000.0 in Q1 2022, and down 52.86% on a QoQ basis from $210000.0 in Q1 2022.

LeonaBio (LONA) has 4 years of Shares Issued data on file, last reported at $99000.0 in Q1 2023.

  • Quarterly Shares Issued fell 52.86% year-over-year to $99000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $309000.0 (up 254.5% YoY) and the FY2025 annual result came in at $90.0 million, changed N/A from the prior year.
  • Shares Issued slipped to $99000.0 in Q1 2023 per LONA's latest filing, from $210000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $97.2 million in Q1 2021 and bottomed at -$410000.0 in Q2 2021.
  • The 4-year median for Shares Issued is $210000.0 (2022), against an average of $23.7 million.
  • The widest annual swing landed in 2022, when Shares Issued plunged 99.78%; it then slumped 52.86% in 2023.
  • Tracing LONA's Shares Issued over 4 years: stood at $21.3 million in 2020, then tumbled by 101.93% to -$410000.0 in 2021, then soared by 151.22% to $210000.0 in 2022, then tumbled by 52.86% to $99000.0 in 2023.
  • Per Business Quant, the three latest LONA Shares Issued figures stand at $99000.0 (Q1 2023), $210000.0 (Q1 2022), and -$410000.0 (Q2 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 5.40 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 27.00 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 163.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 13.16 Mn
10 LeonaBio 181.52 Mn 113.84 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 99,000.00
Mar 31, 2023 99,000.00
Mar 31, 2022 210,000.00
Mar 31, 2022 210,000.00
Jun 30, 2021 -410,000.00
Jun 30, 2021 -410,000.00
Mar 31, 2021 97.17 Mn
Mar 31, 2021 97.17 Mn
Dec 31, 2020 21.29 Mn
Dec 31, 2020 21.29 Mn